These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relation between renal and hepatic excretion of drugs: XV. Organ distribution and transport of the new antiarrhythmic drug Bonnecor in kidney and liver of rats. Fleck C, Bräunlich H. Exp Pathol; 1991; 42(3):137-44. PubMed ID: 1915757 [Abstract] [Full Text] [Related]
4. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm]. Lozinskiĭ LG, Zamotaev IP, Zeltyn'-Abramov EM, Orlov VA, Beloborodov VL, Kosilova EE, Zalesskaia MA, Tiukavkina NA. Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386 [Abstract] [Full Text] [Related]
5. [Anti-arrhythmic effect and kinetic parameters of bonnecor in the treatment of extrasystole in patients with acute myocardial infarction]. Ol'binskaia LI, Sizova ZhM, Tiukavkina NA, Beloborodov VL, Kosilova EE, Kobeleva TA. Kardiologiia; 1990 Dec; 30(12):9-11. PubMed ID: 1711135 [Abstract] [Full Text] [Related]
6. Relation between renal and hepatic excretion of drugs: XIII. Pharmacokinetics of new antiarrhythmic drug Bonnecor in rats with normal and impaired excretory functions. Fleck C, Richter S, Tischendorf G, Klemm W, Bräunlich H. Exp Pathol; 1989 Dec; 36(3):165-75. PubMed ID: 2503392 [Abstract] [Full Text] [Related]
9. Pharmacokinetic investigations of Craviten. IV. First-pass metabolism in rats. Danek A, Witek J. Pol J Pharmacol Pharm; 1980 Dec; 32(6):949-53. PubMed ID: 7243692 [Abstract] [Full Text] [Related]
11. [Possibilities for increasing the elimination rate of Bonnecor]. Fleck C, Schilder L, Schulze U, Pfister M, Stein G, Landmann H, Schwachula G, Bräunlich H. Z Gesamte Inn Med; 1990 Oct 15; 45(20):604-9. PubMed ID: 2129177 [Abstract] [Full Text] [Related]
14. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat]. Klemm W, Morgenroth U, Joram U, Rodionov AP. Pharmazie; 1985 Dec 15; 40(12):864-7. PubMed ID: 3841605 [Abstract] [Full Text] [Related]
16. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals]. Gaete LE, Ortiz M, Soto J, Saavedra I. Rev Med Chil; 1995 Jun 15; 123(6):713-9. PubMed ID: 8525224 [Abstract] [Full Text] [Related]
17. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor]. Sokolov SF, Golitsyn SP, Malakhov VI, Bankuzov VA, Koltunova MI, Golitsyn LS. Farmakol Toksikol; 1990 Jun 15; 53(3):57-60. PubMed ID: 2387385 [Abstract] [Full Text] [Related]
18. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats. Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR. Xenobiotica; 2006 Sep 15; 36(9):838-56. PubMed ID: 16971347 [Abstract] [Full Text] [Related]